MASSACHUSETTS GENERAL HOSPITAL
Eliminating the Immunogenicity of AAV Vectored HIV Antibody Delivery
Eliminating the Immunogenicity of AAV Vectored HIV Antibody Delivery is a funding opportunity from MASSACHUSETTS GENERAL HOSPITAL, up to 819586, closing December 31, 2028.
Dec 31, 2028
(884d left)Overview
Project Summary / Abstract This proposal describes the framework of an R01 grant for Alejandro Balazs, PhD. Dr. Balazs is currently an assistant professor at Harvard Medical School working as a principal investigator at the Ragon Institute of MGH, MIT & Harvard. Dr. Balazs’ research is focused on engineering the…